SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-255830
Filing Date
2014-06-30
Accepted
2014-06-30 16:30:57
Documents
4
Period of Report
2014-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d750349d8k.htm 8-K 17580
2 EX-10.1 d750349dex101.htm EX-10.1 537765
3 GRAPHIC g750349g14c25.jpg GRAPHIC 110996
4 GRAPHIC g750349g97a11.jpg GRAPHIC 106081
  Complete submission text file 0001193125-14-255830.txt   856204
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 14949388
SIC: 2834 Pharmaceutical Preparations